AKAP12 and prostate carcinoma: Several direct targets have been identified, including AKAP12 in hepatocellular carcinoma, PTEN in non-small-cell lung cancer and D52 in prostate cancer, have been reported to be targets of miR-103a-3p [38, 41, 44].